The Dan Show

We've always said the most important work at Arrive AI happens at the seams — where hardware meets software, where machines meet people, and where today's deployments become tomorrow's network. This episode lives at every one of those seams. First, Attila Nagy walks us through what it actually takes to engineer a delivery endpoint that has to work outdoors, across climates, alongsid...

Before an Arrive Point™ is deployed in the real world, it's tested and refined in simulations. In this episode of The Dan Show, Dan and Kylie sit down with Tanmay Haldankar, one of the robotics engineers powering Arrive AI's (NASDAQ: ARAI) technical operations.  Tanmay walks through how the team uses NVIDIA Isaac Sim and NVIDIA Blackwell GPU workstations to train, test, and refine the ne...

Dan and Kylie share the big news that our show is now syndicated on major podcast platforms, then we confront two NASDAQ notices head-on with the clearest facts we can share. We explain what the notices mean, why we believe the upside is bigger than the downside, and what we are building next across AI, investors, and patents. • two NASDAQ notices tied to market cap and public float • how we think...

We talk with Ankeith, CEO and founder of Sky Air, about why India is sprinting ahead in autonomous drone delivery and what it takes to scale from impressive pilots to millions of real drops. We break down why physical AI infrastructure is the make-or-break layer for last-mile autonomy, then zoom in on the tech and operations behind Level 4 and Level 5 drones.  • Our partnership in India and why a...

We celebrate John Galena’s appointment to the CVS board while he stays on our board, and we share why that healthcare alignment matters. We also lay out why we believe Arrive AI is stronger than ever on people, cash, facility, and IP even as the stock price hits new lows.  • John Galena joining the CVS board while remaining on our board  • Why healthcare leadership and Fortune 500 validation matte...

We sit down with Rithiker Vijay, CEO and founder of Autonomy, to talk about what finally makes delivery robots scale in the real world. The big unlock is not just better navigation, but smart infrastructure that removes the human-in-the-loop handoff and turns pilots into repeatable ROI.  • why the next decade belongs to physical AI and robotics  • Nvidia’s ecosystem and why partners matter even fo...

We look our Arrive Ai shareholders in the eye, lay out eight months of real progress, and bring in our tech lead to explain how a software-first platform becomes the backbone for autonomous delivery. The build is accelerating toward end-to-end demos, with major partners leaning in. • eight-month milestones from hiring to HQ and NVIDIA Connect • why the share price lags execution • team depth acros...

At Arrive Ai, we share real progress behind the glossy headlines: new hires, NVIDIA-powered engineering, and why asynchronous pickup is the missing layer for robots to deliver value. Hospital results, CES meetings, and a candid take on stock price show where execution meets trust. • 2025 milestones since going public and scaling the team • NVIDIA program access and on-prem compute to accelerate bu...

We share how Arrive AI moves from vision to installations, highlight a smart city launch at Peachtree Corners, and welcome FedEx veteran Laurie Tucker to our board to tackle the high cost of last-mile logistics. We also clarify share splits, celebrate new partnerships, and preview plans for a NYC celebration. • smart city installation at Curiosity Lab in Peachtree Corners • 5G connectivity enablin...

We share breaking news: acceptance into NVIDIA’s Connect program and what it unlocks for our AI roadmap, delivery speed, and long-term vision. From team shoutouts to plans around NVIDIA Thor, we explain why this milestone matters and how it raises our bar. • joining NVIDIA Connect and why it matters • direct access to NVIDIA tools and experts • faster development and lower costs • team expertise w...

We share how the new HQ accelerates engineering, why transparency matters even pre-revenue, and how a double flywheel between robots, drones, and arrive points can unlock a universal last-yard standard. We also talk Russell index adds, institutional holders, capital discipline, and a 2026 NASDAQ bell. • rapid move into new building and open house • expanded hiring across AI, robotics, software, pr...

We celebrate joining the Russell 2000, share a first look at our new 30,000 sq ft HQ, and dig into early hospital results that free up clinician time. Dan previews an AI panel in New York and clarifies our flexible share buyback plan and why it matters. • Russell 2000 induction and why it matters • New headquarters move, layout and signage • Team growth across engineering, AI and operations • New...

We confront the share price head-on while laying out a five-year plan focused on scale, recurring revenue, and an autonomy platform rooted at the edge. The team is growing fast, investor interest is strong, and live installs prove the tech works in the wild. • acknowledging market volatility and shareholder concerns • celebrating the Nasdaq milestone and sustained optimism • expanding the team acr...

We share the highs of our first earnings call as a public company, the boardroom energy that followed, and the hospital deployment proving autonomous handoffs can free clinicians to focus on care. The plan is bold: protect IP, scale to 100,000 units, and execute with rigor. • first earnings call prep and key takeaways • five-year roadmap to 10x company valuation • patent strategy and recent heatin...

We recap the Nasdaq opening bell, the whirlwind behind-the-scenes work, and how a napkin sketch in 2014 became a public company. We share hiring plans, a potential Bitcoin treasury strategy, global partnerships, and a save-the-date for a closing bell on July 14. • key moments from ringing the Nasdaq opening bell • the origin story from napkin sketch to patent to launch • Bloomberg mention and the...

We share a major patent win that brings temperature-controlled, UV-disinfected, secure delivery to the curb and set plans to ring the Nasdaq bell on July 3 in Times Square. We ask our community to RSVP, show up, and help turn a milestone into a movement. • patent securing heated and cooled cargo area with UV disinfecting and hazard detection • why climate control unlocks healthcare, pharma, food •...

We share the post‑announcement high, then shift into execution: first revenue from a hospital robot deployment, trading realities, and a call to expand our reach together. Culture stays open as we focus on outcomes, hiring, and long‑term value over day‑to‑day swings. • gratitude for supporters and a non‑stop virtual celebration • reaffirming open culture and direct communication • early trading co...

We share the raw emotions and real logistics of taking our company public, from SEC effectiveness and share status to the timing of our first NASDAQ trade. We lay out how to find your shares through Odyssey, why we traded before the bell ceremony, and how to join our all-day celebration. • gratitude to early investors and supporters • explanation of restricted vs unrestricted shares • confirmation...

We share a clear, step‑by‑step plan to access shares through Odyssey, prepare a brokerage for transfer, and get ready for trading day. We also reflect on the long path to listing, outline launch‑day plans, and explain how to mark shares to limit borrowing. • Odyssey holding and email instructions • Separate communications for StartEngine, WeFunder, PIG Me • One‑for‑four reverse split and reference...

We close the crowdfund, share gratitude for the first 5,000 investors, and outline the path to a public listing with a planned $40 million raise to scale. We talk transparency, stewardship, and a Guinness World Record bell-ringing celebration in New York. • crowdfund closed and five million raised combined  • appreciation for first 3,000 and first 5,000 investors  • why crowdfunding ends and move...

We share why we moved to one long crowdfunding extension, where the SEC review stands, and what remains before a Nasdaq listing. We explain the final funding push, the audits, the plan for a record-setting bell ringing, and how investors will transfer shares for trading. • rationale for a single long crowdfunding extension • final-mile funding need and current progress • transparency on S-1 commen...

We share a candid New Year update on our path to going public, including the S-1 filing, Nasdaq review, and why we chose a one-for-four reverse split. We explain timing, costs, past deal attempts, and how optionality keeps us moving toward a New York celebration as co-owners. • S-1 filing publicly disclosed and why it matters • Waiting on SEC comments and Nasdaq approval linkage • New York listing...

We explain the reverse split, the $13 pricing target, and why it broadens access to institutional investors while preserving value. We outline S-1 progress, share logistics with the transfer agent, realistic timing for listing, and how we’ll keep everyone informed and involved. • why a reverse split aligns with NASDAQ rules and investor screens • how $13 pricing improves access to funds and market...

We lay out clear investor updates, the path to a direct NASDAQ listing, and why we chose the ticker ARAI. We also share our first fully autonomous delivery milestone and how share transfers will work at listing. • Share price moving from 304 dollars to 325 dollars on 15 October • Minimum investment increasing to 1,000 dollars • Direct listing targeted for Q4 2024 • Ticker selection process and cho...